Clinical trial
Combination Chemotherapy as Induction Therapy in Treating Patients With Stage…
NCT00003037 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003037 |
|---|---|
| Title | Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer |
| Official title | Phase I/II Trial of the Combination of Docetaxel, Gemcitabine and Cisplatin (DGP) as Induction Chemotherapy in Patients With Stage III Non-Small Cell Lung Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, docetaxel, gemcitabine hydrochloride |
| Start date | Apr 1, 1997 |
| Primary completion | Mar 1, 2002 |
| Completion | Mar 1, 2002 |
| First posted | Nov 25, 2003 |
| Last update posted | Jun 27, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: